Chapter 7: GTM Like an OG

Let's destroy the myth that a product launch is simply hitting "publish" on a press release and hoping for a miracle. In the current market, "stealth mode" is just a synonym for "invisible"—if nobody hears about your launch, it didn't happen. We are going to teach you how to move beyond the one-and-done splash to create a Go-to-Market (GTM) signal that hits harder than a moose call in Algonquin Park.

In this chapter, we cover:

• The 3-Phase Launch Sequence (Awareness → Activation → Adoption): A breakdown of why a true GTM strategy isn't a single event but a well-structured progression. We cover how to build thought leadership to get your name out there (Awareness), how to get early adopters and Key Opinion Leaders to try your solution through pilots (Activation), and how to establish long-term loyalty and track ROI (Adoption).
• Why Launches Fail (and How to Prevent It): An exploration of the "Hockey Puck Pitfalls" that cause startups to hit a wall after their initial lab buzz. We detail how to spot and navigate Market-Product Misfits, the Capital Crunch, Talent Tangles, and Regulatory Roadblocks before they sink your venture.
• The Canadian Channels and Tactics That Work for GTM in Life Sciences: How to stop shouting into the void and start strategically leveraging the unique strengths of the Ontario ecosystem. You will learn to build essential connections through government advocacy groups (like LSO and OBIO), academic and research hubs (like UHN and McMaster Innovation Park), and targeted community networking events.
• Glow-to-Market Timelines and Tools That Actually Work: A reality check that going to market in life sciences is a multi-year canoe trip through the wilderness, not a quick sprint to the dep. We discuss how to plan for the "slog of regulatory approvals" and "Byzantine procurement" processes, when to embrace fractional expertise, and how to set realistic expectations for your milestones.

Transcript

Kris 0:00

Chapter 7. GTM Like an OG Gizmo, are we ready to stop treating launch day like it's just hitting publish on a press release and praying for a miracle?

Gizmo 0:12

My analysis indicates that 98% of press releases are read only by the author's mother and a lonely web crawler bot. This is not a strategy. It is digital silence.

Tangela 0:27

From the offices of All Good Life Science Marketing, deep inside the Mars Innovation Hub, this is the Ontario Life Science Founders Marketing Glow Up. A 14-chapter commercialization playbook, serialized as a podcast. Don't just listen, do the work. Kickstart your glow up with the Free Marketing Foundation's workbook. Five essential step-by-step exercises to craft your venture's commercial platform. Grab your copy now at allgoodmarketing.ca. Now here's Ontario's favorite new marketing duo. All good marketing president and educator, Chris Barnett, and his high fidelity hype dog, Gizmo.

Kris 1:15

Welcome back to the Ontario Life Sciences founder Marketing Glow Up.

Gizmo 1:20

The 14-chapter audio playbook serialized as a podcast where we transform invisible innovators into commercial beasts.

Kris 1:29

We are broadcasting from the All-Good Life Science Marketing Office at the Mars Innovation Hub. We are the agency that helps you break the commercialization chokehold by making sure when you finally speak, the market actually listens. Today we are learning that if nobody hears about your launch, it didn't happen.

Gizmo 1:52

Warning. Stealth mode detected. In the current market, stealth is often a synonym for invisible.

Kris 2:00

Exactly. We're going to teach you how to create a signal, not just noise. We're moving beyond the one and done splash to build a campaign that hits harder than a moose call in Algonquin Park.

Gizmo 2:14

Initiating awareness, activation, and adoption sequence. Let's glow.

 GTM like an OG

Kris 2:24

Chapter 7. GTM Like an OG. It's not a launch if nobody hears about it. Welcome to the Glow to Market Guide that finally speaks Founder. Let's be real. You've been hustling in the lab, chasing breakthroughs, probably living off lukewarm coffee and sheer willpower. You've got the science locked down, maybe even scored some early wins that made the folks at home proud, eh? But it's not a launch if nobody hears about it. Most Ontario founders think launch day means hitting publish on a press release. Wrong. That's just noise. What you need is a signal, a carefully orchestrated, persona-driven launch campaign that matches your market's behavior. Think of it like dropping a sick Zed's dead beat that everyone has to dance to. In this chapter, we walk through the complete GTM anatomy, from the pre-hype whisper campaign to the big reveal and beyond. You'll learn how to position your company for different buyers, what channels hit hardest in Canadian health tech, and what your first 90 days post-launch should really look like. We'll bust the myth that GTM has to be expensive, showing you low-cost tactics that deliver high returns. This chapter is about mindset as much as mechanics. The

The 3-phase launch sequence: Awareness - Activation - Adoption

Kris 3:49

three-phase launch sequence. Awareness, activation, adoption. Forget the one and done splash. A true go-to-market GTN strategy is like a well-structured three-chord progression, building from a quiet intro to a full-on Leonard Cohen-like anthem. It moves through distinct phases. Awareness, where your target audience first recognizes you, activation, where they're compelled to try, engage, or learn more, and adoption, where your brand becomes a consistent, integrated part of their world. This isn't just about getting eyes on your product, it's about embedding it into the market's DNA. Just as the Ontario government recognizes the need for increased awareness of public policy initiatives to promote opportunities and signal an open-for-business climate in biotech, your launch must clearly communicate your value proposition. Traction plan. Awareness. Get your name out there beyond the lab walls. This is where you make some noise, louder than a moose call in Algonquin Park. It's about ensuring your target audience, be it clinicians, researchers, or industry partners, knows your solution exists and why it matters. You're not just selling a product, you're selling a vision of improved healthcare and a better future for Ontarians. Focus on thought leadership and content marketing. Leverage Ontario's world-class science and research ecosystem by sharing your discoveries in accessible ways. Publish white papers, speak at industry conferences, engage with relevant media, and use social channels to explain the impact of your innovation, not just the science. Increasing awareness of public policy initiatives and the range of support available for startups and entrepreneurs in the life sciences sector could help promote opportunities within the industry. For science to advance, for innovation to reach patients waiting in Canada, your narrative should explain how your innovation improves patient outcomes and strengthens the healthcare system.

Gizmo 6:12

Marketing Nerd Alert. This phase relies heavily on the ADA, Attention, Interest, Desire, Action Model, with a focus on attention and interest. It's also rooted in content marketing theory, which holds that valuable content is created to attract and engage a clearly defined audience.

Kris 6:39

No free samples, but maybe a pilot. Once folks know you, they need to experience you. This phase is about getting your early adopters to test or pilot your solution. For life sciences, this often means navigating clinical trials or proof-of-concept project. Identify key opinion leaders, KOLs, and early adopter institutions in Ontario. We have strong academic centers and healthcare institutions like UHN, which treats Canada's sickest patients and is driven by unmet needs. Ontario is a leader in clinical trials, boasting 22,000 plus researchers and staff. Work with organizations like Clinical Trials Ontario, CTO, to reduce launch times, offer pilot programs or limited access trials that demonstrate tangible value and gather crucial feedback. This isn't just about data, it's about building trust and proving the real-world efficacy of your solution.

Gizmo 7:49

Marketing Nerd Alert. This maps to the desire and action stages of IDA. And critically, to the concept of a minimum viable product, MVP, from the Lean Startup methodology, allowing for rapid iteration based on user feedback.

Kris 8:12

The True North, strong and free users. This is the long game. It's about ensuring continued use, positive word of mouth, and ultimately, integrating your solution into standard practice. Think long-term relationships, not a hit and run. Implement robust customer success programs. Provide exceptional support. Gather feedback constantly, and iterate based on user experience. Build a community around your product. Perhaps a user group that feels like a cozy Canadian potluck. Seek testimonials and case studies from your early adopters. Focus on demonstrating the return on investment for healthcare systems or the improved patient outcomes that result.

Gizmo 9:04

Marketing Nerd Alert. This phase embodies customer relationship management, CRM principles, and the network effect, in which the value of your product increases as more users adopt it, driving a self-sustaining growth cycle.

Kris 9:21

Exercise 7-1. The Eh List Launch Canvas. Description. Stop treating your launch like a one-and-done splash and start building a signal. In this exercise, you will map out a three-phase go-to-market sequence awareness, activation, and adoption. Identifying the specific Ontario audiences, key messages, and success metrics required to embed your innovation into the market's DNA rather than just getting eyes on it. Goal. Align your launch tactics with your market's behavior to ensure sustained adoption rather than fleeting noise. Exercise worksheets are provided in the accompanying commercialization workbook.

Gizmo 10:10

Marketing Nerd Alert. This exercise aligns with the traditional marketing funnel. Awareness, top of funnel, tofu, activation, middle of funnel, mofu, and adoption, bottom of funnel, BoFu. It also touches on relationship marketing and customer lifecycle management.

Why launches fail (and how to prevent it)

Kris 10:34

Why launches fail and how to prevent it? Let's face it, GTM isn't all butter tarts and sunshine. Many promising innovations, even with top-tier science, can face a brutal Manitoba winter and fail to launch successfully. Why? Often it's a confluence of factors, not unlike a hockey team with a potent offense but a leaky defense. Far too many hit a wall after the initial lab buzz. In Ontario's life sciences sector, the dream often collides with a few harsh realities. A significant challenge is the industry's capital-intensive nature, which struggles to access private and public capital. There's also a recognized talent gap at the executive and senior management levels, alongside a lack of experienced executives with deep knowledge of product commercialization, sales, and marketing, and a shortage of available mentorship. While Canada is a research powerhouse, excelling in discovery, we've historically struggled with commercialization. Companies often struggle to scale into larger firms, causing promising ventures to leave for better resourced ecosystems. The hockey puck pitfalls. Market product misfit. The wrong stick for the puck. You've built something brilliant, but does anyone actually need it? Or is the market too small? It's not about creating a product that you believe would be a nice thing to give to the world. You really need to choose a product with a large market. Capital Crunch, the Empty Timmy's Cup. Innovation is expensive, and Canada has a historical challenge in accessing capital for life sciences. A 2018 survey by Bio to Canada highlighted that 57% of respondents identified access to capital as the top issue. Ontario lags other North American jurisdictions in venture capital investment per capita. This shortage can stall growth and force companies to look south of the border. Talent Tangle. No one to skate with you. You might be a scientific wizard, but scaling a business requires different hats: sales, marketing, operations, and finance. Startups in Ontario struggle to navigate the commercialization and launch phases due to a lack of experienced executives with deep expertise in product commercialization, sales, and marketing. The talent gap, particularly at the C-suite and higher managerial levels, is a recognized barrier. Regulatory roadblocks and procurement potholes, the bureaucratic backcheck. Canada's regulatory and reimbursement systems can be complex and fragmented. For pharmaceuticals, the average time from global authorization to public reimbursement is 2.5 years, compared to just eight months in the US. This slow path to market can deter the adoption of innovation. Validate early and often pre-game scrimmage. Before investing heavily, engage potential customers and stakeholders. What problems are they actually trying to solve? How does your solution fit into their existing workflows? Adopt the lean startup approach. Build, measure, and learn. Things take longer than you expect, so be patient and resilient. Strategic capital acquisition. Powerplay funding. Don't just raise money, raise smart money. Look for investors who understand the unique long-term cycles of life sciences. Leverage Ontario's supportive ecosystem. The provincial government is investing $15 million in the Life Sciences Innovation Fund, LSIF, to support companies in developing and launching homegrown medical technologies in Ontario. Obio places strong emphasis on programming under three key pillars, including capital access, which enables companies to secure the financing they need. AdMare Bioinnovations helps build companies and ecosystems and is always seeking investment partners. Venture Ontario Fund is dedicating an additional $40 million to the life sciences. Build a dream team. Assemble the all-stars. Recognize your own limitations. You don't have to be a jack of all trades. A good CEO is only as good as his team. Find the people that you want to marry, those with complementary skill sets. Look for fractional leadership or advisory roles to fill C-suite gaps. BioTalent Canada helps small and medium-sized businesses shore up their talent strategies by teaching them how to find and retain the brightest and best talent. Navigate the system. Skate around the obstacles. Engage with industry associations like Life Sciences Ontario, LSO, and Obio. Early. They advocate for policy changes and provide valuable insights into market access. Don't underestimate the importance of collaboration with the government and stakeholders to determine how to approach this together. Exercise 7-2. Postmortem Premortem, your what-if scenario planner. Description. Instead of waiting for failure, predict it. You will fast forward to a hypothetical failed launch and work backward to identify the specific hockey puck pitfalls, from capital crunches to regulatory roadblocks, and define proactive prevention strategies to mitigate these risks before they sink your venture. Goal. Identify potential failure points early to build a resilient, defensible, go-to-market strategy. Exercise worksheets are provided in the accompanying commercialization workbook.

Gizmo 16:59

Marketing Nerd Alert. This exercise forces you to think about root cause analysis and apply principles of strategic planning and risk mitigation in a marketing context. It emphasizes the importance of market product fit and a go-to-market model that extends beyond the product itself.

The Canadian channels and tactics that work for GTM in life sciences

Kris 17:19

The Canadian channels and tactics that work for GTM in life sciences. You've got a stellar product, a team that could win the Stanley Cup, and you've dodged the major GTM potholes. Now, how do you actually get your solution into the hands of Canadian healthcare professionals and patients? It's not about being loud, it's about being smart, leveraging the unique characteristics of the great White North's life sciences landscape. The life sciences sector in Canada isn't merely buzzing, it's a full-on symphony with Ontario in the lead. The province is a powerhouse of innovation, with 3,500 firms contributing $15 billion to GDP and supporting 88,000 jobs. We have smart people, strong academic centers affiliated with healthcare institutions, diverse populations, and a strong talent base. The Southern Ontario-Quebec Corridor is a hub for AI and healthcare innovation. The crucial point isn't what you say, but where you say it and to whom. Think strategic connections, polite persistence, and tapping into that inherent Canadian collaborative spirit. Strategic government engagement and advocacy, the diplomatic dance. The Ontario government has a clear life sciences strategy to position the province as a global hub for biomanufacturing and life sciences. They're prioritizing unlocking new streams of capital and supporting the existing ecosystem. They even have a life sciences council to inform strategy development. Unlike some jurisdictions, the Canadian life sciences sector works hand in hand with the government. Organizations like Life Sciences Ontario, LSO, are a strong voice for the government on policies that support our industry, from basic research to commercialization and procurement. Ontario Bioscience Innovation Organization, OBIO, actively engages in strategy, programming, policy development, and advocacy to further the commercialization of Ontario's health science companies. They focus on capital access, workforce development, and technology adoption. Traction Plan. Attend policy roundtables, join industry associations, and stay informed about government funding initiatives such as the Life Sciences Innovation Fund, LSIF, and the Wet Labs program to address space shortages. Academic and Research Hub Partnerships, the Lab to Lounge Link. Ontario boasts an extraordinary research enterprise with world-class universities and hospitals. Institutions like the University of Toronto, McMaster, and UHN are powerhouses of innovation. McMaster Innovation Park, MIP, for instance, focuses on helping entrepreneurs, innovators, and ventures start, scale, and thrive by providing innovation infrastructure and an ecosystem for commercialization. Its partnership with OmniBio for biomanufacturing is a massive deal for the region. The Synapse Consortium in Hamilton serves as a concierge or facilitator, connecting private and public organizations with local infrastructure, expertise, and capabilities. Traction Plan. Collaborate with University Technology Transfer Offices, TTOs, establish research partnerships with leading academic laboratories, and engage with innovation hubs such as the Mars Discovery District. They are critical for de-risking IP and securing funding. Community and networking events, the big hockey game huddle. Canadians love a good gathering. Events like the next great big idea summit in Hamilton are explicitly designed to bring together industry leaders, startups, executives, investors, academics, and members of the public to build connections. Traction Plan. Actively participate in networking events. Life Sciences Ontario. A leading industry organization serves as a central hub for the community, offering numerous networking and educational events. These events are excellent opportunities to build relationships, discover mentors, and explore potential collaborations. Digital presence with a local twist. The edgy online persona. While global, your digital strategy should acknowledge the Canadian context. Highlight the made in Ontario aspect of your innovations. Traction Plan. Develop strong online content that resonates with Canadian values. Perhaps focusing on improving health outcomes for Canadians, a common theme among our leaders. Leverage data and AI to inform decisions, as Bettina Hamlin of Ontario Genomics emphasizes. Exercise 7-3. The Maple Leaf Marketing Mix, your Canadian channel checklist. Description. Stop shouting into the void and start leveraging the unique strengths of the Ontario ecosystem. This checklist guides you to identify and activate high-impact Canadian channels, from government advocacy and academic hubs to local industry events, ensuring you build the strategic connections necessary for a successful local launch. Goal. Pinpoint specific Canadian channels and partners to maximize your local ecosystem leverage and support. Exercise worksheets are provided in the accompanying commercialization workbook.

Gizmo 23:40

Marketing Nerd Alert. This exercise applies principles of channel strategy, target audience segmentation, and content marketing within a localized niche market. It also highlights the importance of public relations and stakeholder engagement in a highly regulated sector.

Glow-to-Market Timelines and Tools That Actually Work

Kris 24:05

Let's be brutally honest, founders. Going to market in life sciences isn't a quick sprint to the depth for a 2-4. It's more like a multi-year canoe trip through the Canadian wilderness, long, sometimes arduous, and absolutely requires the right gear and a realistic map. The arduous path to commercialization, with cost-intensive and lengthy payback periods, is a widely acknowledged reality in our sector. In the life sciences, expecting rapid progress is a recipe for disappointment. Things will also take longer than you expect them to. And if you don't build the slog of regulatory approvals and byzantine procurement processes into your planning, you're going to get sunk. You're probably sunk already if you don't have a solid understanding of what procurement in huge organizations, especially governmental ones, looks like by the time your market-ready product is supposed to go to market. If your product has regulatory approval, also understand that procurement at the target organizations occurs in large waves and follows very specific time intervals. Embrace the long haul and the detours. Patience isn't just a virtue, it's a survival skill in this industry. Recognize that adversity makes you stronger, and that disappointment, rejection, and constructive conflict should be welcomed as the crucible in which great firms are created. This polite persistence, exemplified by admir bioinnovations, proves reliable to investors by doing what you say you're going to do. Something key when things inevitably get bumpy. Be a pivot master, or find one. Persistence, but the ability to pivot when necessary and knowing when to admit that something isn't working out are the keys to building a successful startup. Make decisions as quickly as possible based on the data and be prepared to correct them post-haste. This flexibility and iteration are crucial for navigating the unpredictable journey. Leverage fractional expertise. You don't need a full-time expert for every stage. Fractional leadership can provide senior leadership and hands-on support without the full-time cost. This allows you to tap into specialized knowledge in areas such as fundraising, strategy, and commercialization, ensuring you're not going it alone. Admir Bioinnovations, for instance, actively builds companies, ecosystems, and talent, offering leadership programs to address senior talent gaps. Follow the data, eh? Your gut instinct is good, but the data is golden. Be absolutely committed to following the data wherever it takes you. This rigorous, evidence-based approach is fundamental in science and should extend to your GTM strategy. Exercise 7-4, the Maple Syrup Milestone Map. Description. Going to market in life sciences is a multi-year canoe trip, not a sprint. In this exercise, you will plot a realistic timeline from your current stage to full market adoption, explicitly mapping critical dependencies like regulatory submissions and clinical trials against required resources to ensure you don't run out of cash or momentum. Goal: Create a realistic, resource-aligned timeline that accounts for the long cycles and dependencies of life science's commercialization. Exercise worksheets are provided in the accompanying commercialization workbook.

Gizmo 28:11

Marketing Nerd Alert. This exercise integrates project management principles with agile marketing and the lean startup methodology. It emphasizes the importance of key performance indicators, KPIs.

Conclusion

Kris 28:27

Conclusion, rock the market, not just the lab. Okay, Ontario Founders, you now have your roadmap. And it isn't just about hoping for the best. Instead, it is about a comprehensive strategy that relentlessly and even ruthlessly pursues market relevance. You achieve this by mastering the market and moving beyond what we in Ontario often accept as a fait accompli for product launches. Mission Launched. One, understand the three phases of launch. Two, diagnose what happens when things go wrong. Ontario is a place of great innovation, and we strive to make it a global leader in the life sciences industry's GDP. We want all Ontarians to have access to life-changing products and services. But this is not only about the accessibility of life-altering stuff, it is also about economic prosperity. We are on the path to Canadian life sciences prosperity, equipped with all the necessary tools and pieces to drive the life sciences industry to boom here. We must bring all these tools together with a strong go-to-market GTM strategy.

Gizmo 29:50

So, a go-to-market strategy is not a sprint of a depth. It is a multi-year canoe trip.

Kris 29:57

It's a long paddle, Giz. We learned that a real launch follows a three-part progression: awareness, activation, and adoption. You can't just drop the product and run. You have to embed it into the market's DNA.

Gizmo 30:13

We also identified the hockey puck pitfalls. Market product misfit and the capital crunch are high probability failure points.

Kris 30:22

That's right. We talked about why you need to validate early and leverage the Ontario ecosystem, like LSO and Obio, to navigate those regulatory potholes. And remember, if you need help napping out that maple syrup milestone map, the team at All Good Marketing is ready to grab a paddle and help you navigate the rapids.

Gizmo 30:44

Rerouting. Optimizing for polite persistence.

Kris 30:49

That's the Canadian way. Up next, chapter 8. Pitch Like You Already Raised.

Gizmo 30:57

We are going to turn your presentation into a performance.

Kris 31:00

We're going to teach you how to map your narrative to an investor's brain and use your IP as commercial armor.

Gizmo 31:08

Translating Science Project into Venture Capital Magnet.

Kris 31:13

Keep glowing, Ontario.

Gizmo 31:15

Until next time, stay commercial, beasts.

Tangela 31:20

Don't just listen, do the work. Kickstart your glow up with the Free Marketing Foundation's workbook. Five essential step by step exercises to craft your venture's commercial platform. Grab your copy now at allgoodmarketing.ca